Ralliant (RAL) Q4 2025 earnings review
Growth Returns, But a $1.4 Billion Hole Appears
Ralliant finally pivoted to positive sales growth (+1% YoY) in Q4, driven by the defensive strength of its Sensors & Safety Systems segment. However, the headline is a massive $1.4 billion non-cash goodwill impairment in Test & Measurement, effectively admitting the EA Elektro-Automatik business has collapsed in value due to slowing EV adoption. While Adjusted EPS of $0.69 beat expectations, the quality of earnings is mixed: S&SS is carrying the load while T&M shrinks. FY26 guidance suggests an acceleration to ~7% growth, but the margin recovery path looks steep.
🐂 Bull Case
Sensors & Safety Systems grew 6% YoY and maintained a healthy 25.1% operating margin. Demand from secular 'super cycles'—grid modernization and defense spending—remains robust and is shielding the company from industrial weakness.
Total revenue growth flipped positive for the first time in three quarters (+1% YoY). Guidance for Q1 26 forecasts further acceleration to +5-8% YoY, suggesting the worst of the inventory destocking and cyclical lows are behind them.
🐻 Bear Case
The $1.4B impairment charge in Test & Measurement is massive—exceeding the entire quarter's revenue of $555M. It signals a severe miscalculation of the EA business's value and the EV market's trajectory.
Adjusted EBITDA margin fell 500 basis points YoY to 20.8%. While some of this is spin-related cost, T&M margins specifically collapsed from 23.4% (24Q3) to 15.9% (25Q4) as volume deleverage hurts profitability.
⚖️ Verdict: ⚪
Neutral. The return to top-line growth and strong FY26 guidance are positives, but the $1.4B write-down is a jarring reminder of execution risks in the EV/Auto exposure. Ralliant is currently a one-engine plane (S&SS) trying to restart its second engine (T&M) mid-flight.
Key Themes
The $1.4 Billion EV Mistake
Ralliant recorded a $1.4B goodwill impairment in the Test & Measurement segment, specifically tied to the EA Elektro-Automatik business. Management cited 'slower-than-anticipated progression' and reduced forecasts for EV adoption. This is a major admission that previous assumptions about the EV testing market were overly optimistic, effectively erasing years of perceived value creation in that unit.
Sensors & Safety Systems (S&SS) Resilience
S&SS remains the company's backbone, delivering $337M in revenue (+6% YoY). The segment benefits from long-tail secular trends: utilities investing in grid expansion for data centers/electrification, and global defense spending. Unlike the cyclical T&M business, S&SS provides a stable floor for cash flow.
Test & Measurement Profitability Plunge
T&M is not just shrinking in sales (-6% YoY); it is hemorrhaging profitability. Adjusted EBITDA margin for the segment fell to 15.9% in Q4, down drastically from ~22% in Q2 and ~23% a year ago. Management blames lower revenue and higher employee costs, but this degree of margin compression suggests high fixed costs that are difficult to shed during downturns.
Ramping Innovation in Validation Workflow
Despite the write-down, Ralliant is doubling down on T&M innovation. Building on the Q3 launch of the MP5000 modular test system (targeting validation workflows) and DPO7000, management noted 'ramped innovation' as a key priority for 2026. These products are critical to pivoting the T&M segment away from pure hardware cyclicality toward integrated validation solutions.
Semiconductor & China Headwinds Persist
The T&M decline (-6%) was attributed to prior-year project comparisons in the Semiconductor space. While management previously noted stabilization in China, the market remains tough. The impairment charge linked to EV adoption also implicitly flags continued weakness in automotive, a key market for China and Western Europe.
Capital Allocation: Buybacks & Dividends
Despite the reported net loss, cash flow remains robust ($102M Operating CF). Ralliant paid its first post-spin dividend ($0.05/share) and has a fully available $200M share repurchase authorization. With the stock likely to be volatile following the impairment news, the company has the dry powder to support the share price.
Other KPIs
Stable sequentially (vs 20.4% in Q3) but down significantly from 25.8% a year ago. The company is battling dis-synergies from the spin-off and volume deleverage in T&M. The guidance for Q1 26 (17-18%) implies a step-down due to seasonality before recovering later in the year.
Down from $147M in the prior year, but conversion remains strong. For the full year, Free Cash Flow Conversion exceeded 95%, validating the company's ability to generate cash even while reporting GAAP losses due to non-cash charges.
Decelerating decline. The -6% YoY drop is an improvement from -14% in Q3 and -15% in Q2. Sequential growth was +7%. This suggests the segment may have found a floor, though the recovery slope is shallow.
Guidance
Accelerating YoY. The range implies +5% to +8% growth vs Q1 25. Sequentially, this is a decline from Q4 ($555M), but management notes this is consistent with typical seasonality. It signals confidence that the YoY growth inflection in Q4 was not a fluke.
Decelerating. This is a drop from 20.8% in Q4 25. Management attributes this to higher operating expenses and investments in growth strategy. It indicates that the 'cost savings' programs are not yet outpacing the new standalone public company costs.
Stable/Accelerating. The midpoint ($2.15B) implies ~4% growth over FY25 ($2.07B). This assumes the recovery continues throughout the year.
The midpoint ($2.32) represents a decline from the pro-forma/adjusted annualized run rate of FY25 (FY25 adjusted Net Earnings were $305M, or ~$2.69/share). This reflects the full burden of standalone costs and interest expense that weren't present for the full duration of FY25.
Key Questions
The EA Business Future
After a $1.4B write-down on the EA Elektro-Automatik business, is the unit still strategic to Ralliant? Are further restructuring actions or a potential divestiture of this asset on the table if EV headwinds persist?
Margin Bridge to 20%
Guidance for Q1 26 margins is 17-18%, yet the full year target is 18-20%. What specific levers (volume leverage vs. cost cuts) drive the ramp in profitability in H2, especially given the persistent fixed cost issues in T&M?
T&M Recovery Shape
T&M improved from -15% growth to -6%. With the semiconductor recovery pushed out and EV slowing, do you expect T&M to turn positive YoY in Q1 26, or will S&SS continue to mask T&M declines?